Study finds male infants at increased risk for NAS

Male infants are more likely at birth than their female counterparts to be diagnosed with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), and to require treatment, according to a new Vanderbilt study published in Hospital Pediatrics.

American Academy of Pediatrics, Vanderbilt neonatologist urge public health approach for women who use opioids during pregnancy

Standardizing care improves outcomes for infants born with neonatal abstinence syndrome

Standardizing hospital care policies across institutions for infants diagnosed with drug withdrawal symptoms at birth reduces their length of treatment and hospitalization, according to new research led by Vermont Oxford Network, Vanderbilt and the University of Michigan Health System.

Infants born with NAS more likely to be readmitted: Study

Infants diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS), are nearly 2.5 times as likely to be readmitted to the hospital in the first month after being discharged compared with full-term infants born without complications, according to new Vanderbilt research released in the journal Hospital Pediatrics.

VUMC’s Patrick speaks to members of congress about neonatal abstinence syndrome

Stephen Patrick, M.D., MPH, assistant professor of Pediatrics and Health Policy in the Division of Neonatology with the Monroe Carell Jr. Children’s Hospital at Vanderbilt, recently testified before congress about the rise in neonatal abstinence syndrome.

Babies born with drug withdrawal symptoms on rise

The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period.